Peter Noyce

1

• Peter Noyce

2
Revalidation for Pharmacists

• Professor P R Noyce
• Director, The Workforce Academyand Professor of
  Pharmacy PracticeUniversity of Manchester

3
Managing symptoms
Bissell et al (1997)
4
Clinical autonomy and occupational status
Magirr et al (2004)
5
Likelihood of pharmacists reporting locallyvs
nationally
Nationally
Locally
Ashcroft et al (2005)
6
Fitness to Practice
7

• Knowing is not enough we must apply
• Willing is not enough we must do

Goethe (1742-1832)
8
Maintaining Competence in Pharmacy

• Recommended minimum period of continuing education

Mandatory record of continuing professional
development
(Regulation of pharmacy technicians 2007)
Revalidation of pharmacists? - post
Shipman enquiry- post Foster review
9
The burgeoning case forrevalidation of
pharmacists?

• Growing clinical involvement carries increased
  professional risk.
• Comparatively high level of isolated practice and
  locum activity.
• Increasing recognition of importance of acts of
  omission, as well as commission.
• Evolving regulatory responsibility for
  performance.
• Revalidation becoming the norm for health
  professions.

10
Whats happening elsewhere?

• Ontario (Canada) College of Pharmacy
• Compulsory quality assurance (revalidation)
  programme since 1996

• Institute of Medicine (USA)
• Recommends State Boards to implement mandatory
  evidence-based assessments of continuing
  competency, 2003

• Pharmacy Council of New Zealand
• Mandatory recertification, 2006

• College of Pharmacy of British Columbia (Canada)
• Assessment process designed and validated, 2006

11
The Challenge

• To devise a revalidation scheme that

• is robust
• is efficient
• has the confidence of the public, profession and
  Government

12

• Peter Noyce